Acute effect of sildenafil on hypoxemic patients (excluding those with Eisenmenger syndrome) with incurable congenital heart disease and disturbed pulmonary vasculature in the mid-term follow-up

International Journal of Cardiology

Volumn 146, Issue 2, 2011, Pages 273-274

  Mitani, Yoshihide ^a   Ohashi, Hiroyuki ^a   Takabayashi, Shin ^a   Shimpo, Hideto ^a   Komada, Yoshihiro ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Cavopulmonary shunt; Congenital heart disease; Cyanosis; Hypoplastic pulmonary artery; Pulmonary hypertension; Sildenafil

Indexed keywords

SILDENAFIL;

CLINICAL ARTICLE; CONGENITAL HEART DISEASE; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; HYPOXEMIA; INFANT; LETTER; LOADING DRUG DOSE; LUNG BLOOD FLOW; LUNG BLOOD VESSEL; MALE; PRIORITY JOURNAL; PULMONARY VASCULAR DISEASE;

EID: 78651435546     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.10.080     Document Type: Article

References (6)

1. G.P. Diller, and M.A. Gatzoulis Pulmonary vascular disease in adults with congenital heart disease Circulation 115 2007 1039 1050
2. S. Mukhopadhyay, M. Sharma, and S. Ramakrishnan Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study Circulation 114 2006 1807 1810
3. H.A. Ghofrani, R. Wiedemann, and F. Rose Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial Lancet 360 2002 895 900
4. M. Lévy, C. Danel, D. Tamisier, P. Vouhé, and F. Leca Histomorphometric analysis of pulmonary vessels in single ventricle for better selection of patients for the Fontan operation J Thorac Cardiovasc Surg 123 2002 263 270
5. M. Rabinovitch, V. Herrera-deLeon, A.R. Castaneda, and L. Reid Growth and development of the pulmonary vascular bed in patients with tetralogy of Fallot with or without pulmonary atresia Circulation 64 1981 1234 1249
6. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150